MedTrace Logo

Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels

NCT03310450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2019-10-10

Study results available
· View outcomes & findings →

Summary

Prospective observational study to determine predictors that related to cardiac troponin I (cTnI) release, malondialdehyde (MDA) and high sensitivity C Reactive Protein (hs-CRP) after Tour de Borobudur (TdB) 2017

Conditions

  • Heart Arrest
  • Sport Injury
  • Inflammatory Response
  • Oxidative Stress

Interventions

OTHER

140kms cycling

Main exposure is long distance cycling touring (TdB/NC) consists of three groups; 140kms, 100kms, and 240kms (investigator did not give any treatment/intervention, just observed the cycling touring event)

Sponsors & Collaborators

  • Ministry of Research, Technology and Higher Education, Republic of Indonesia

    collaborator UNKNOWN

  • Universitas Diponegoro

    collaborator OTHER

  • Universitas Negeri Semarang

    lead OTHER

Principal Investigators

  • Mahalul Azam, Dr · Universitas Negeri Semarang

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-28
Primary Completion
2017-11-11
Completion
2018-05-05

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03310450 on ClinicalTrials.gov